Commerce Bank’s Emergent Biosolutions EBS Stock Holding History

Commerce Bank’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,661	Closed	-$284K	–	1181
2021 Q3	$284K	Sell	5,661 -330	-6%	-$20K	﹤0.01%	1020
2021 Q2	$378K	Sell	5,991 -15	-0.2%	-$964	﹤0.01%	925
2021 Q1	$558K	Sell	6,006 -1,295	-18%	-$133K	﹤0.01%	774
2020 Q4	$654K	Buy	7,301 +1,625	+29%	+$149K	0.01%	686
2020 Q3	$586K	Buy	5,676 +1,024	+22%	+$110K	0.01%	645
2020 Q2	$368K	Buy	+4,652	New	+$347K	﹤0.01%	769

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Commerce Bank's EBS Position: Q4 2021 in Review

Commerce Bank sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 5,661 shares — an estimated $284K sold.

Commerce Bank first reported a position in EBS in Q2 2020 and held it in 6 quarters. The position peaked at $654K in Q4 2020. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

Commerce Bank reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
Commerce Bank sold 5,661 Emergent Biosolutions shares in Q4 2021, an estimated $284K.
Commerce Bank first reported a position in Emergent Biosolutions in Q2 2020 and held it in 6 quarters.
Commerce Bank's Emergent Biosolutions position peaked at $654K in Q4 2020.
254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Commerce Bank's 13F filing for Q4 2021, filed 14 Feb 2022.